NCT01544049

Brief Summary

The purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention. This will be done through a paper questionnaire and phone interviews. The investigators hope to gain information that will allow us to better counsel women about ovarian cancer prevention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 28, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 5, 2012

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 4, 2018

Completed
Last Updated

September 12, 2018

Status Verified

September 1, 2018

Enrollment Period

6.8 years

First QC Date

February 28, 2012

Last Update Submit

September 11, 2018

Conditions

Ovarian Cancer

Keywords

fallopian tube removalsalpingectomyovarian cancer prevention

Outcome Measures

Primary Outcomes (1)

  • Describe subject experience in undergoing Salpingectomy as a means of riks reduction

    Subjects will provide information on their reason for choosing salpingectomy and the process they went through in undergoing this procedure

    At conclusion of study

Study Arms (1)

Fallopian tube removal

Women who have had one or both fallopian tube(s) removed as method of ovarian cancer prevention.

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women who have had their fallopian tubes removed as a method of ovarian cancer prevention.

You may qualify if:

  • Female of at least 18 years of age
  • Must speak English fluently
  • Have had fallopian tubes removed as a method of ovarian cancer prevention

You may not qualify if:

  • Males
  • Females under the age of 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington

Seattle, Washington, 98195, United States

Location

MeSH Terms

Conditions

Ovarian Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Study Officials

  • Elizabeth Swisher, MD

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 28, 2012

First Posted

March 5, 2012

Study Start

December 1, 2011

Primary Completion

September 4, 2018

Study Completion

September 4, 2018

Last Updated

September 12, 2018

Record last verified: 2018-09

Locations

US(1)